A recent in silico analysis of DDIT4 expression in several cancer types showed that the high expression of this gene was related to a bad outcome in diverse hematologic and solid tumors, such as acute myeloid leukemia, breast cancer, glioblastoma multiforme, melanoma, lung, and colon cancer. The gene discussed is DDIT4; the disease is breast carcinoma.